Literature DB >> 27252160

The VCD Mouse Model of Menopause and Perimenopause for the Study of Sex Differences in Cardiovascular Disease and the Metabolic Syndrome.

H L Brooks1, D P Pollow2, P B Hoyer2.   

Abstract

In females, menopause, the cessation of menstrual cycling, is associated with an increase in risk for several diseases such as cardiovascular disease, osteoporosis, diabetes, the metabolic syndrome, and ovarian cancer. The majority of women enter menopause via a gradual reduction of ovarian function over several years (perimenopause) and retain residual ovarian tissue. The VCD mouse model of menopause (ovarian failure in rodents) is a follicle-deplete, ovary-intact animal that more closely approximates the natural human progression through perimenopause and into the postmenopausal stage of life. In this review, we present the physiological parameters of how to use the VCD model and explore the VCD model and its application into the study of postmenopausal disease mechanisms, focusing on recent murine studies of diabetic kidney disease, the metabolic syndrome, and hypertension. ©2016 Int. Union Physiol. Sci./Am. Physiol. Soc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27252160      PMCID: PMC5504385          DOI: 10.1152/physiol.00057.2014

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  31 in total

Review 1.  Reproductive aging and risk for chronic disease: Insights from studies of nonhuman primates.

Authors:  Susan E Appt; Kelly F Ethun
Journal:  Maturitas       Date:  2010-04-28       Impact factor: 4.342

2.  Midkine, a heparin-binding protein, is increased in the diabetic mouse kidney postmenopause.

Authors:  Maggie K Diamond-Stanic; Melissa J Romero-Aleshire; Patricia B Hoyer; Kevin Greer; James B Hoying; Heddwen L Brooks
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

3.  Endocrine function of the peri- and postmenopausal ovary.

Authors:  T Ushiroyama; O Sugimoto
Journal:  Horm Res       Date:  1995

4.  Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats.

Authors:  L N Springer; M E McAsey; J A Flaws; J L Tilly; I G Sipes; P B Hoyer
Journal:  Toxicol Appl Pharmacol       Date:  1996-08       Impact factor: 4.219

5.  Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

Authors:  Jacques E Rossouw; Ross L Prentice; JoAnn E Manson; Lieling Wu; David Barad; Vanessa M Barnabei; Marcia Ko; Andrea Z LaCroix; Karen L Margolis; Marcia L Stefanick
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

6.  Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

Authors:  A Ferrara; A J Karter; L M Ackerson; J Y Liu; J V Selby
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

7.  Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases.

Authors:  Karen A Matthews; Nanette Santoro; Bill Lasley; Yuefang Chang; Sybil Crawford; Richard C Pasternak; Kim Sutton-Tyrrell; Maryfran Sowers
Journal:  J Clin Endocrinol Metab       Date:  2006-02-21       Impact factor: 5.958

Review 8.  Sex differences in angiotensin II- induced hypertension.

Authors:  B Xue; A K Johnson; M Hay
Journal:  Braz J Med Biol Res       Date:  2007-05       Impact factor: 2.590

9.  The follicle-deplete mouse ovary produces androgen.

Authors:  Loretta P Mayer; Patrick J Devine; Cheryl A Dyer; Patricia B Hoyer
Journal:  Biol Reprod       Date:  2004-03-03       Impact factor: 4.285

Review 10.  Benefits of hormone replacement therapy in postmenopausal women.

Authors:  Richard Canderelli; Lisa A Leccesse; Nancy L Miller; Janice Unruh Davidson
Journal:  J Am Acad Nurse Pract       Date:  2007-12
View more
  32 in total

1.  Using 4-vinylcyclohexene diepoxide as a model of menopause for cardiovascular disease.

Authors:  John P Konhilas; Jessica N Sanchez; Jessica A Regan; Eleni Constantopoulos; Marissa Lopez-Pier; Danielle K Cannon; Rinku Skaria; Laurel A McKee; Hao Chen; Yulia Lipovka; Dennis Pollow; Heddwen L Brooks
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-08       Impact factor: 4.733

Review 2.  Effects of Intrauterine Growth Restriction and Female Sex on Future Blood Pressure and Cardiovascular Disease.

Authors:  Gwendolyn K Davis; Ashley D Newsome; Norma B Ojeda; Barbara T Alexander
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

3.  Interleukin-6 Promotes Murine Estrogen Deficiency-Associated Cerebral Aneurysm Rupture.

Authors:  Daisuke Wajima; Siham Hourani; William Dodd; Devan Patel; Chad Jones; Kartik Motwani; Hanain Z Fazal; Koji Hosaka; Brian L Hoh
Journal:  Neurosurgery       Date:  2020-04-01       Impact factor: 4.654

4.  Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice.

Authors:  Jeffrey B Mason; Kate C Parkinson; Tracy L Habermehl
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

5.  Androgen Receptor Blockade Differentially Regulates Blood Pressure in Growth-Restricted Versus Ovarian Deficient Rats.

Authors:  Gwendolyn K Davis; Suttira Intapad; Ashley D Newsome; Laura E Coats; Daniel R Bamrick; Norma B Ojeda; Barbara T Alexander
Journal:  Hypertension       Date:  2019-08-05       Impact factor: 10.190

6.  Estrogen Receptor β Contributes to Both Hypertension and Hypothalamic Plasticity in a Mouse Model of Peri-Menopause.

Authors:  Teresa A Milner; Natalina H Contoreggi; Fangmin Yu; Megan A Johnson; Gang Wang; Clara Woods; Sanoara Mazid; Tracey A Van Kempen; Elizabeth M Waters; Bruce S McEwen; Kenneth S Korach; Michael J Glass
Journal:  J Neurosci       Date:  2021-05-03       Impact factor: 6.167

Review 7.  The Interrelationship Between Female Reproductive Aging and Survival.

Authors:  Jeffrey B Mason; Tracy L Habermehl; Kaden B Underwood; Augusto Schneider; Miguel A Brieño-Enriquez; Michal M Masternak; Kate C Parkinson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-01-07       Impact factor: 6.591

8.  Development of a Chemical Reproductive Aging Model in Female Rats.

Authors:  Nayara Pestana-Oliveira; Ruither O G Carolino; Bruna Kalil-Cutti; Cristiane M Leite; Litamara C Dalpogeto; Bruna Balbino De Paula; John P Collister; Janete Anselmo-Franci
Journal:  Bio Protoc       Date:  2021-04-20

Review 9.  Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.

Authors:  Cinzia Perrino; Péter Ferdinandy; Hans E Bøtker; Bianca J J M Brundel; Peter Collins; Sean M Davidson; Hester M den Ruijter; Felix B Engel; Eva Gerdts; Henrique Girao; Mariann Gyöngyösi; Derek J Hausenloy; Sandrine Lecour; Rosalinda Madonna; Michael Marber; Elizabeth Murphy; Maurizio Pesce; Vera Regitz-Zagrosek; Joost P G Sluijter; Sabine Steffens; Can Gollmann-Tepeköylü; Linda W Van Laake; Sophie Van Linthout; Rainer Schulz; Kirsti Ytrehus
Journal:  Cardiovasc Res       Date:  2021-01-21       Impact factor: 10.787

10.  Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging.

Authors:  Zachary S Clayton; David A Hutton; Sophia A Mahoney; Douglas R Seals
Journal:  Aging Cancer       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.